Read + Share
Wu TT, Zheng YY, Wang ZL, Pan Y, et al. A Nearly 50% Risk of MACCE Cutdown by Personalized Antiplatelet Therapy: The
Subgroup Analysis of Hypertension in PATH-PCI Trial. Catheter Cardiovasc Interv 2025;106:1723-1731.
PMID: 40605149
|
 |
|
Wu TT, Zheng YY, Wang ZL, Pan Y, et al. A Nearly 50% Risk of MACCE Cutdown by Personalized Antiplatelet Therapy: The
Subgroup Analysis of Hypertension in PATH-PCI Trial. Catheter Cardiovasc Interv 2025;106:1723-1731.
PMID: 40605149
|
|
|
|